Goodwin Procter advised a syndicate of investors on the deal. Bird & Bird advised SparingVision. SparingVision, a genomic medicines company with a mission to translate pioneering...
SparingVision’s €75 Million Series B Financing
NMD Pharma’s €35 Million Financing Round
Mazanti-Andersen advised Jeito Capital on the deal. The Danish biotech company NMD Pharma A/S has raised EUR 35 million in a financing round led by new...
EyeBio’s $65 Million Series A Financing
Goodwin advised SV Health, Jeito and Samsara BioCapital on the deal. SV Health, Jeito and Samsara BioCapital led a $65 million Series A Financing of EyeBio. EyeBio...
Pulmocide’s $92 Million Series C Financing Round
Goodwin Procter LLP advised Jeito Capital on the deal. Jeito Capital, a rapidly emerging independent Private Equity firm dedicated to biotech and biopharma, announced that it has led...